ECMC Announcement – Over 1,800 lung cancer patients screened through stratified medicine initiative
Over 1,800 patients have been screened through the Stratified Medicine Programme Phase 2 (SMP2), with the 100th patient being recruited to the National Lung Matrix Trial (NLMT) in November 2016.
